Wan Jun, Thurm Abby R, Allen Sage J, Ludwig Connor H, Patel Aayan N, Bintu Lacramioara
Department of Bioengineering, Stanford University, Stanford, CA, 94305.
Present address: Pharma Technical Development, Genentech, South San Francisco, CA, 94080.
bioRxiv. 2024 Nov 3:2024.11.01.621523. doi: 10.1101/2024.11.01.621523.
Controlling gene expression and chromatin state via the recruitment of transcriptional effector proteins to specific genetic loci has advanced the potential of mammalian synthetic biology, but is still hindered by the challenge of delivering large chromatin regulators. Here, we develop a new method for generating small nanobodies against human chromatin regulators that can repress or activate gene expression. We start with a large and diverse nanobody library and perform enrichment against chromatin regulatory complexes using yeast display, followed by high-throughput pooled selection for transcriptional control when recruited to a reporter in human cells. This workflow allows us to efficiently select tens of functional nanobodies that can act as transcriptional repressors or activators in human cells.
通过将转录效应蛋白招募到特定基因位点来控制基因表达和染色质状态,推动了哺乳动物合成生物学的发展潜力,但仍受到递送大型染色质调节因子这一挑战的阻碍。在此,我们开发了一种针对人类染色质调节因子生成小型纳米抗体的新方法,这些纳米抗体能够抑制或激活基因表达。我们从一个庞大且多样的纳米抗体库开始,利用酵母展示针对染色质调节复合物进行富集,随后在招募到人类细胞中的报告基因时,通过高通量混合筛选进行转录控制。这种工作流程使我们能够高效地筛选出数十种功能性纳米抗体,它们在人类细胞中可作为转录抑制因子或激活因子发挥作用。